about
Uptake of atrial fibrillation screening aiming at stroke prevention: geo-mapping of target population and non-participationQuality of oral anticoagulation with phenprocoumon in regular medical care and its potential for improvement in a telemedicine-based coagulation service--results from the prospective, multi-center, observational cohort study thrombEVALCardiovascular and non-cardiovascular hospital admissions associated with atrial fibrillation: a Danish nationwide, retrospective cohort study.The effect of integrated cardiac rehabilitation versus treatment as usual for atrial fibrillation patients treated with ablation: the randomised CopenHeartRFA trial protocol.The Cost of Thromboembolic Events and their Prevention among Patients with Atrial Fibrillation.Economic impact of longer battery life of cardiac resynchronization therapy defibrillators in Sweden.Cost-effectiveness of pharmacogenetics in anticoagulation: international differences in healthcare systems and costs.Cost effectiveness of antiarrhythmic medications in patients suffering from atrial fibrillation.Cost-of-illness studies of atrial fibrillation: methodological considerations.Anti-thrombotic therapy in patients with atrial fibrillation and intracranial hemorrhage.Cost effectiveness of adding dapagliflozin to insulin for the treatment of type 2 diabetes mellitus in the Netherlands.Cost-effectiveness analysis of rivaroxaban for treatment and secondary prevention of venous thromboembolism in the Netherlands.Atrial fibrillation prevalence revisited.Cost of illness of atrial fibrillation: a nationwide study of societal impact.Cost of Illness for Five Major Foodborne Illnesses and Sequelae in Sweden.Point-of-care monitoring of warfarin treatment in community dwelling elderly--A randomised controlled study.Warfarin persistence among atrial fibrillation patients - why is treatment ended?
P2860
Q34892646-4F8FDA62-9510-4264-B801-736AEDDD4DEFQ35099559-DBC6E409-8203-423D-847A-BE39ADA9AAF4Q36584176-FC86AC48-CA82-4F3F-91A3-D2BA33DBEC77Q36650126-6ADAA6CC-469B-4AD9-88FA-61B9F0B53005Q37115008-E9621D7F-B648-41C8-BD27-B1FEFB700AAAQ37395605-2A8C000D-5B9A-4A72-BB03-052718F39BF4Q38042441-FB6D7558-8711-4CCF-9DF8-40D5CB66ABBEQ38084943-33508F89-1775-49B6-945B-69B1A4CC84B2Q38232326-42786D8B-752D-4FFF-947F-266270EF4302Q38236837-01C72D3F-3C6B-4A24-A979-6D6DA0EFD396Q38441105-F2D5AC4A-378D-4856-ADDE-8E53FA39C977Q40196279-0FF5DE18-44CD-49A1-B26D-8B8C1FF93771Q45114135-71E4C9A3-1E12-4552-B504-2D2ADEE573B9Q47148155-E3EF4915-3D56-463C-8DFD-60BCE8E6B640Q47192757-D116556D-E42E-4C96-BEAF-D0856282F5BDQ48046077-394157B8-99FA-4978-8A4D-D9E397410DEBQ51836770-2BB78086-04D0-4F60-B3F0-DBB625D09D5A
P2860
description
2010 nî lūn-bûn
@nan
2010 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Atrial fibrillation: the cost of illness in Sweden
@ast
Atrial fibrillation: the cost of illness in Sweden
@en
type
label
Atrial fibrillation: the cost of illness in Sweden
@ast
Atrial fibrillation: the cost of illness in Sweden
@en
prefLabel
Atrial fibrillation: the cost of illness in Sweden
@ast
Atrial fibrillation: the cost of illness in Sweden
@en
P2093
P2860
P1476
Atrial fibrillation: the cost of illness in Sweden
@en
P2093
Ingela Björholt
Lennart Bergfeldt
Lisa Ericson
P2860
P2888
P304
P356
10.1007/S10198-010-0261-3
P577
2010-07-01T00:00:00Z